Ram Felix S F, Wedzicha Jadwiga A, Wright John, Greenstone Michael
National Collaborating Centre for Women and Children's Health, London NW1 4RG.
BMJ. 2004 Aug 7;329(7461):315. doi: 10.1136/bmj.38159.650347.55. Epub 2004 Jul 8.
To evaluate the efficacy of hospital at home schemes compared with inpatient care in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD).
A systematic review of randomised controlled trials.
Mortality and readmission to hospital.
Seven trials with 754 patients were included in the review. Hospital readmission and mortality were not significantly different when hospital at home schemes were compared with inpatient care (relative risk 0.89, 95% confidence interval 0.72 to 1.12, and 0.61, 0.36 to 1.05, respectively). However, compared with inpatient care, hospital at home schemes were associated with substantial cost savings as well as freeing up hospital inpatient beds.
Hospital at home schemes can be safely used to care for patients with acute exacerbations of COPD who would otherwise be admitted to hospital. Clinicians should consider this form of management, especially as there is increasing pressure for inpatient beds in the United Kingdom.
评估与住院治疗相比,居家医院模式对慢性阻塞性肺疾病(COPD)急性加重患者的疗效。
对随机对照试验进行系统评价。
死亡率和再入院率。
该评价纳入了7项试验,共754例患者。将居家医院模式与住院治疗相比较时,再入院率和死亡率无显著差异(相对风险分别为0.89,95%置信区间0.72至1.12;以及0.61,0.36至1.05)。然而,与住院治疗相比,居家医院模式可大幅节省费用,还能腾出医院的住院床位。
居家医院模式可安全用于护理那些原本需住院治疗的COPD急性加重患者。临床医生应考虑这种管理形式,尤其是在英国住院床位压力不断增加的情况下。